SouthState’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
SouthState's BIIB Position: Q3 2026 in Review
SouthState increased its Biogen (BIIB) stake by 100% in Q3 2026, buying an estimated $8.91K and bringing the position to 84 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #628.
SouthState first reported a position in BIIB in Q1 2017 and has held it in 20 quarters since. The position peaked at $403K in Q3 2017. 897 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.
- SouthState held 84 shares of Biogen worth $19K as of Q3 2026.
- SouthState bought 42 Biogen shares in Q3 2026, an estimated $8.91K.
- Biogen made up ﹤0.01% of SouthState's portfolio in Q3 2026, its #628 holding.
- SouthState first reported a position in Biogen in Q1 2017 and has held it in 20 quarters since.
- SouthState's Biogen position peaked at $403K in Q3 2017.
- 897 funds tracked by Wall St. Rank held Biogen as of Q3 2026.
Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.